Provectus Biopharmaceuticals, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
PVCT on OTC
Industry
Pharmaceutical Preparations
Location
800 S. Gay Street, Suite 1610, Knoxville, TN

There are no Buy or Sell transactions made by insiders since 10/18/2023

Provectus Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Lacy III Director Sep 30, 2024
Eric Wachter Cto Jun 17, 2021
Edward Pershing CEO, Director Oct 16, 2024
Bruce Horowitz COO, Director Jun 17, 2021
Dominic Rodrigues PRESIDENT, Director Sep 30, 2024
Jeffrey Allen Morris 10%+ Owner Aug 12, 2024
Heather Raines Cfo Feb 28, 2024
Webster Bailey Director Sep 30, 2024

Recent Insider Transactions by Companies or Individuals for Provectus Biopharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.